BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29901088)

  • 1. Fasudil preserves lung endothelial function and reduces pulmonary vascular remodeling in a rat model of end‑stage pulmonary hypertension with left heart disease.
    Zhuang R; Wu J; Lin F; Han L; Liang X; Meng Q; Jiang Y; Wang Z; Yue A; Gu Y; Fan H; Zhou X; Liu Z
    Int J Mol Med; 2018 Sep; 42(3):1341-1352. PubMed ID: 29901088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
    Chen XY; Dun JN; Miao QF; Zhang YJ
    Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of pulmonary hypertension secondary to left ventricular dysfunction in the rat by Rho-kinase inhibitor fasudil.
    Dai ZK; Wu BN; Chen IC; Chai CY; Wu JR; Chou SH; Yeh JL; Chen IJ; Tan MS
    Pediatr Pulmonol; 2011 Jan; 46(1):45-59. PubMed ID: 20717937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
    Zhang X; Zhang T; Gao F; Li Q; Shen C; Li Y; Li W; Zhang X
    Mol Med Rep; 2015 Nov; 12(5):7317-25. PubMed ID: 26458725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats.
    Li F; Xia W; Li A; Zhao C; Sun R
    Pharmacol Res; 2007 Jan; 55(1):64-71. PubMed ID: 17127075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fasudil on hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats.
    Sun XZ; Tian XY; Wang DW; Li J
    Eur Rev Med Pharmacol Sci; 2014; 18(7):959-64. PubMed ID: 24763873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.
    Rashid J; Nahar K; Raut S; Keshavarz A; Ahsan F
    Mol Pharm; 2018 May; 15(5):1755-1765. PubMed ID: 29528655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
    Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
    Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
    Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
    Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
    Wu F; Yao W; Yang J; Zhang M; Xu Y; Hao Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
    Biomed Pharmacother; 2017 Nov; 95():1161-1168. PubMed ID: 28926926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the RhoA/ROCK pathway in high-altitude associated neonatal pulmonary hypertension in lambs.
    Lopez NC; Ebensperger G; Herrera EA; Reyes RV; Calaf G; Cabello G; Moraga FA; Beñaldo FA; Diaz M; Parer JT; Llanos AJ
    Am J Physiol Regul Integr Comp Physiol; 2016 Jun; 310(11):R1053-63. PubMed ID: 26911462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
    Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
    Yasuda T; Tada Y; Tanabe N; Tatsumi K; West J
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L667-74. PubMed ID: 21856816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
    Li FH; Xia W; Li AW; Zhao CF; Sun RP
    Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
    Peng G; Ivanovska J; Kantores C; Van Vliet T; Engelberts D; Kavanagh BP; Enomoto M; Belik J; Jain A; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2599-611. PubMed ID: 22505643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.
    Wong MJ; Kantores C; Ivanovska J; Jain A; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L985-L999. PubMed ID: 27694473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoA/ROCK may involve in cardiac hypertrophy induced by experimental hyperthyroidism.
    Na W; Peng G; Jianping Z; Yanzhong C; Shengjiang G; Li C
    Toxicol Ind Health; 2012 Oct; 28(9):831-9. PubMed ID: 22072613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats.
    Jiang BH; Tawara S; Abe K; Takaki A; Fukumoto Y; Shimokawa H
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):85-9. PubMed ID: 17312448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.